CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 14, 2022 · earnings

SLS earnings: a negative outcome, -44.0%

On November 14, 2022, SELLAS Life Sciences Group, Inc. reached its earnings. The result was a negative outcome, and the stock moved -44.0% in the window around the event. It had already run +138.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$4.55
1d before
$2.55
Event day
$2.24
1d after
$2.60
5d after

Pre-catalyst setup

+138.2%
30-day run-up
15796%
30-day volatility
1.0×
volume spike